Gornitzky represented the underwriters, led by TD Cowen and Guggenheim Securities on the offering. UroGen Pharma Ltd. secured a USD 107.5 million follow-on public offering of...
UroGen Pharma’s Follow-on Public Offering
Monte Rosa Therapeutics’ $100 Million Underwritten Public Offering
Goodwin Procter advised Monte Rosa Therapeutics, while Paul Hastings advised TD Cowen and Wedbush PacGrow, as joint book-running managers, in the offering. Monte Rosa Therapeutics, Inc....
Ichor Holdings’ $125 Million Shares Offering
Orrick represented TD Cowen and Stifel as joint book-running managers and representatives of several underwriters in the offering. Ichor Holdings, Ltd. executed a $125 million public offering....
Humacyte’s $40 Million Public Offering
Covington & Burling represented Humacyte, while Paul Hastings advised TD Cowen, Cantor and BTIG in the offering. Humacyte, Inc. executed an underwritten public offering of 13,400,000 shares...
Jasper Therapeutics’ $50 Million Common Stock Offering
Paul Hastings LLP advised Jasper Therapeutics, Inc., while DLA Piper advised the underwriters. Jasper Therapeutics, Inc. (Nasdaq: JSPR), a clinical-stage biotechnology company focused on developing novel...
Tenaya Therapeutics’ $50 Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised Tenaya Therapeutics on the transaction, and Davis Polk & Wardwell advised the underwriters. Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage...
Olema Pharmaceuticals’ $150 Million At-the-Market Offering
Cooley advised Olema Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised TD Cowen, as sales agent. Olema Pharmaceuticals ((“Olema”, Nasdaq: OLMA) announced its $150...
TD Cowen’s Sale of Continental European Investment Banking Business
Bär & Karrer acted as legal advisor to TD Cowen in this transaction. CMS advised the partners in the transaction TD Cowen, a division of TD...
Atara Biotherapeutics’ $100 Million Common Stock Offering
Sidley Austin represented Atara Biotherapeutics, Inc. in the offering, and Davis Polk & Wardwell represented TD Cowen, as the sales agent. Atara Biotherapeutics, Inc. (Nasdaq:ATRA) (“Atara”)...
Alector’s $125 Million At-The-Market Offering
Wilson Sonsini Goodrich & Rosati represented Alector, Inc. in the offering, and Davis Polk & Wardwell represented TD Cowen, as sales agent. Alector, Inc. (“Alector”) (Nasdaq:ALEC)...
Harpoon Therapeutics’ $150 Million Private Placement
Paul Hastings LLP advised TD Cowen and the placement agents in connection with Harpoon Therapeutics’ offering. Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing novel T...
Inventiva’s $58 Million At-The-Market Offering
Gide Loyrette Nouel and Cooley represented Inventiva S.A. on the offering. Davis Polk & Wardwell and Linklaters TD advised Cowen, as the sales agent. Inventiva S.A....